Ophthalmology
Galimedix Therapeutics Inc. is focused on clinical research in ophthalmology, with attention to degenerative retinal disease and structural preservation of the eye.
- Retinal disorders
- Vision-threatening disease
- Age-related eye disease
The sponsor’s current clinical activity is centered on conditions affecting the retina and the progression of macular degeneration.
Geographic Atrophy
Its research landscape includes geographic atrophy, particularly non-foveal geographic atrophy associated with non-neovascular age-related macular degeneration.
- Geographic atrophy lesion progression
- Non-neovascular AMD
- Retinal degeneration
Clinical interest is directed toward slowing changes in GA lesion size and addressing advanced dry age-related macular degeneration.
Ocular Therapeutics
The sponsor is engaged in development of ophthalmic solutions for local treatment of retinal pathology, with emphasis on eye-targeted therapy.
- Topical ocular treatment
- Retina-directed therapy
- Visual function preservation
Its therapeutic focus includes interventions intended for patients with progressive retinal atrophy and related ocular disease.
Clinical Research in Macular Disease
Galimedix Therapeutics Inc. is active in clinical research on macular disease, particularly disorders that affect the central retina and surrounding non-foveal regions.
- Macular pathology
- Retinal imaging endpoints
- Disease progression monitoring
Its funded trial activity reflects interest in dry age-related macular degeneration and the clinical burden of progressive retinal atrophy.
